Validation pour Ingenuity236

vers la météo de la validation par utilisateur

Ingenuity236

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 14 - PMID ?

In Hela cells treated with cycloheximide and with zVAD FMK and overproducing SP NODE protein , agonist anti SP Apo 1 [NODE] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a NODE protein protein binding site .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                                          +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 1

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                                          +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 2

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                                          +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 3

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 4

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 5

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
                                                                                                                        +----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
                                                                      +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+------------COMP:V-N(with)------------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 6

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                          +------------------------OBJ:V-N-----------------------+                                                    |                                                                              +----------------OBJ:V-N----------------+   
           |                                                          |          +-------------MOD_ATT:N-ADJ------------+    |                                                    +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           +-------------------------SUBJ:V-N-------------------------+          |       +---------MOD_ATT:N-ADJ--------+    |                           +--------SUBJ:V-N--------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          |       |                 +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+--COMP:N-N(in)-+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       |                 |      +MOD_A+MOD_+         |        +MOD_ATT:+         +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |                 |      |     |    |         |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,Apo)
MOD_ATT:N-ADJ (__SP__,__SP__)
MOD_ATT:N-ADJ (__SP__,__NODE__)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,antibody)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 7

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                                          +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 8

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 9

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +-------------------------SUBJ:V-N-------------------------+----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 10

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 11

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           +-------------------------SUBJ:V-N-------------------------+----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 12

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +-------------------------SUBJ:V-N-------------------------+----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 13

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +----------OBJ:V-N---------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 14

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 15

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 16

                                                                                                                                                         +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 17

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                     +----------------------------------COMP:V-N(In)----------------------------------+                                                                                                                          
           |                                                                                     |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                     |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                     |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                     |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                     |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(In) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 18

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 19

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |      |                                                   +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 20

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |      |                                                   +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 21

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                                          +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 22

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                                          +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 23

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 24

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 25

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 26

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 27

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +----------OBJ:V-N---------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 28

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +-------------------------SUBJ:V-N-------------------------+----------OBJ:V-N---------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 29

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +-------------------------SUBJ:V-N-------------------------+----------OBJ:V-N---------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 30

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 31

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 32

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 33

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +----------OBJ:V-N---------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 34

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+                                      +----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 35

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    |   +------MOD_ATT:N-N------+               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 36

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 37

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 38

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                     +----------------------------------COMP:V-N(In)----------------------------------+                                                                                                                          
           |                                                                                     |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                     |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                     |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                     |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                     |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(In) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 39

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      |                                                   +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 40

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                                                   +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 41

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 42

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      |                                                   +-------MOD_ATT:N-ADJ------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 43

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 44

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
                                                                                                                        |                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
                                                                      +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+------------COMP:V-N(with)------------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 45

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
                                                                                                                        +----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
                                                                      +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+------------COMP:V-N(with)------------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 46

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
                                                                                                                        |                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
                                                                      +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+------------COMP:V-N(with)------------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 47

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 48

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 49

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 50

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                                          +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 51

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 52

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 53

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+               |                      +----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 54

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 55

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 56

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +----------OBJ:V-N---------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 57

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 58

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 59

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    |   +------MOD_ATT:N-N------+               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 60

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 61

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
                                                                                                                                                         +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    +---------------------OBJ:V-N--------------------+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 62

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 63

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 64

                                                                                                                                                         +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 65

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 66

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +--------------------------COMP:V_PASS-N(with)-------------------------+                              |                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            +---MOD_ATT:N-ADJ--+       |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__NODE__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 67

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 68

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           +------------------------------------COMP:N-N(with)-----------------------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,protein)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 69

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 70

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 71

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
                                                         +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 72

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
                                                         +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
                                                         |            +----------OBJ:V-N---------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                                      |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 73

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 74

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 75

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
                                                         +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                         |            +-------MOD_ATT:N-ADJ------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 76

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 77

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 78

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 79

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 80

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+               |                      +----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 81

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 82

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                                             |                                       |         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                                       |         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 83

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+               |                      +----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 84

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                                             |                               |                 +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                               |                 |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                               |                 |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                               |                 |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                               |                 |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +---MOD_ATT:N-ADJ--+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 85

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                                             |                                       |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                                       |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                                       |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                                       |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                                       |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 86

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 87

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 88

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 89

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                                             |                                       |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                                       |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                                       |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                                       |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                                       |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 90

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 91

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 92

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+                                      |                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 93

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |                      |                     +---MOD_ATT:N-ADJ--+       |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 94

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 95

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        |                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
                                                                                                                        |                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    +---------------------OBJ:V-N--------------------+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 96

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +-------MOD_ATT:N-ADJ------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 97

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |      +----------------------COMP:V_PASS-N(with)---------------------+                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      |                             |    |   +------MOD_ATT:N-N------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 98

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+                         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 99

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |      +----------------------COMP:V_PASS-N(with)---------------------+                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      |                             |    |   +------MOD_ATT:N-N------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 100

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                                                                               |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 101

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 102

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 103

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 104

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |                     +---MOD_ATT:N-ADJ--+       |                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 105

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 106

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      +----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                                                   +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 107

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 108

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 109

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +-------MOD_ATT:N-ADJ------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 110

                                                                                                                                                         +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
                                                +---------------------OBJ:V-N--------------------+                                                       +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
                                                |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 111

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
                                                +---------------------OBJ:V-N--------------------+                                                       +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
                                                |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 112

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 113

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 114

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 115

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 116

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 117

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 118

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 119

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 120

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 121

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                                             |                       |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                       |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                       |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                       |                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                       |                         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |                       |                         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 122

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                                             |                               |                 +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                               |                 |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                               |                 |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                               |                 |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                               |                 |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +---MOD_ATT:N-ADJ--+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 123

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 124

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 125

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 126

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 127

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 128

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 129

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 130

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 131

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                                             |                               |                 +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                               |                 |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                               |                 |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                               |                 |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                               |                 |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +---MOD_ATT:N-ADJ--+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 132

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |                      +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 133

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 134

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 135

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 136

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 137

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
                                                                                                                        +----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 138

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                     +----------------------------------COMP:V-N(In)----------------------------------+                                                                                                                          
           |                                                                                     |         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                     |         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +-------MOD_ATT:N-ADJ------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(In) (increase,protein)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 139

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                                                                               |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 140

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                     +----------------------------------COMP:V-N(In)----------------------------------+                                                                                                                          
           |                                                                                     |         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                     |         |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +-------MOD_ATT:N-ADJ------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(In) (increase,protein)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 141

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+               |                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 142

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+                         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 143

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      +--------------------------COMP:V_PASS-N(with)-------------------------+       |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            +---MOD_ATT:N-ADJ--+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__NODE__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 144

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                                              +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                      |                                              |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                                              |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                                              |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                                              |                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    |   +------MOD_ATT:N-N------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 145

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 146

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            +-----SUBJ:V-N-----+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +--OBJ:V-N-+       +OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 147

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 148

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 149

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |      +----------------------COMP:V_PASS-N(with)---------------------+                                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      |                             |    +-------MOD_ATT:N-ADJ-------+               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 150

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |                     +---MOD_ATT:N-ADJ--+       |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 151

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 152

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |      +----------------------COMP:V_PASS-N(with)---------------------+                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      |                             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 153

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                                              +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                      |                                              |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                                              |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                                              |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                                              |                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    |   +------MOD_ATT:N-N------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 154

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      +-------------------------------COMP:V-N(In)-------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 155

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 156

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 157

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 158

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           +------------------------------------COMP:N-N(with)-----------------------------------+                      |                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,protein)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 159

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 160

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           +------------------------------------COMP:N-N(with)-----------------------------------+         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +-------MOD_ATT:N-ADJ------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,protein)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 161

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 162

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 163

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 164

                                                         +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
                                                         |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
                                                         |                       |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
                                                         |                       |                         |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                         |                       |                         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             +---------------------OBJ:V-N--------------------+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 165

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        |                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
                                                +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
                                                |    +-------MOD_ATT:N-ADJ-------+               |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 166

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 167

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 168

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        |                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
                                                         +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
                                                         |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 169

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 170

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                                             |                       |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                       |                         |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |                       |                         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 171

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 172

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 173

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 174

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 175

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 176

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 177

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 178

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 179

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 180

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 181

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                                             |                               |                 +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                               |                 |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +---MOD_ATT:N-ADJ--+       |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 182

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                                             |                                       |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                                       |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                                       |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                                       |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                                       |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 183

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+               |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 184

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 185

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 186

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      |                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 187

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 188

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 189

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 190

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 191

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                      |                      |                       |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |                       |                         |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |                       |                         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 192

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |                      |                     +---MOD_ATT:N-ADJ--+       |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 193

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        |                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 194

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                     +----------------------------------COMP:V-N(In)----------------------------------+                                                                                                                          
           |                                                                                     |         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                     |         |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(In) (increase,protein)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 195

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+               |                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 196

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |                      |                     +---MOD_ATT:N-ADJ--+       |                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 197

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                     +----------------------------------COMP:V-N(In)----------------------------------+                                                                                                                          
           |                                                                                     |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                     |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                     |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                     |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                     |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(In) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 198

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                     +----------------------------------COMP:V-N(In)----------------------------------+                                                                                                                          
           |                                                                                     |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                     |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                     |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                     |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                     |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(In) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 199

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 |                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 200

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 201

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 202

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                      |                      |                               |                 +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |                               |                 |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |                               |                 |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |                               |                 |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |                               |                 |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +---MOD_ATT:N-ADJ--+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 203

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      +----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                                                   +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 204

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           +------------------------------------COMP:N-N(with)-----------------------------------+                      |                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,protein)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 205

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 206

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 207

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 208

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
                                                +---------------------OBJ:V-N--------------------+                                              +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                |    +-------MOD_ATT:N-ADJ-------+               |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 209

                                                         +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
                                                         |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 210

                                                         +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
                                                         |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
                                                         |                       |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
                                                         |                       |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
                                                         |                       |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
                                                         |                       |                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
                                                         |                       |                         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                         |                       |                         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 211

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
                                                         +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 212

                                                         +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
                                                         |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
                                                         |                               |                 +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
                                                         |                               |                 |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |        |            +---MOD_ATT:N-ADJ--+       |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 213

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 214

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 215

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                                             |                       |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                       |                         |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |                       |                         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 216

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 217

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 218

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 219

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 220

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 221

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 222

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 223

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 224

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                                             |                               |                 +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                               |                 |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +---MOD_ATT:N-ADJ--+       |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 225

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |      +----------------COMP:V_PASS-N(with)----------------+                          |                      +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      |      |                      |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 226

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                                             |                       |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                       |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                       |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                       |                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                       |                         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 227

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 228

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 229

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+               |                      |                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 230

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 231

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |      +----------------------COMP:V_PASS-N(with)---------------------+               |                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      |    +-------MOD_ATT:N-ADJ-------+               |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      |      |                      |    |   +------MOD_ATT:N-N------+               |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 232

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           |                                             +------------------------COMP:V-N(with)------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 233

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 234

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 235

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             |    +-------MOD_ATT:N-ADJ-------+               |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 236

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |                      |                                +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |                       |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 237

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |                      +---------------------OBJ:V-N--------------------+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 238

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 239

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 240

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |                      |    +-------MOD_ATT:N-ADJ-------+               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 241

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 242

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |                      |                     +---MOD_ATT:N-ADJ--+       |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 243

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 244

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      |                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 245

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 246

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 |       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      |                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 247

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +--------MOD_ATT:N-N-------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 248

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 249

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 250

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            +-----SUBJ:V-N-----+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +--OBJ:V-N-+       +OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 251

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 252

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 253

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 |                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 254

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 255

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |      +--------------------------COMP:V_PASS-N(with)-------------------------+                              |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            +----MOD_ATT:N-N---+       |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__NODE__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 256

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 257

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 258

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 259

                                                                                                                                                         +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 260

                                                                                                                                                         +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |                     +----MOD_ATT:N-N---+       |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 261

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                                              +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                      |                                              |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    |   +------MOD_ATT:N-N------+               |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 262

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 263

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 264

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-------------------------------COMP:V-N(In)-------------------------------+               |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                       |               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 265

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |      +------------------------------COMP:V_PASS-N(with)-----------------------------+         |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                                                   +--------MOD_ATT:N-N-------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 266

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +--------MOD_ATT:N-N-------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 267

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 268

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 269

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 270

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 271

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 272

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 273

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +--------MOD_ATT:N-N-------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 274

                                                         +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                         |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 275

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 276

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 277

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 278

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 279

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 280

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 281

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 282

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 283

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 284

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 285

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 286

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                                             |                       |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                       |                         |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |                       |                         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 287

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                                             |                       |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                       |                         |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 288

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 289

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 290

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 291

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 292

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 293

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                                             |                                       |         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                                       |         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 294

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 295

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 296

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 297

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+               |                      |                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 298

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                                             |                       |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                       |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                       |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                       |                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                       |                         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 299

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                                              +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                      |                                              |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                                              |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                                              |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    |   +------MOD_ATT:N-N------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 300

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 301

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 302

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                                             |                                       |         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                                       |         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 303

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                                             |                                       |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                                       |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                                       |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                                       |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                                       |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 304

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |                      |    +-------MOD_ATT:N-ADJ-------+               |                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 305

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 306

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      |                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 307

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      |                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 308

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 309

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 310

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 311

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 312

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 313

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 314

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 315

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 316

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 317

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 318

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 319

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 320

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 321

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 322

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 323

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      +----------------COMP:V_PASS-N(with)----------------+                                    |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 324

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                      |                      |                       |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |                       |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |                       |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |                       |                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |                       |                         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |                       |                         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 325

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 326

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 327

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 328

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 329

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +--------MOD_ATT:N-N-------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 330

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                      |                      |                                       |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |                                       |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |                                       |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |                                       |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |                                       |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +--------MOD_ATT:N-N-------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 331

                                                         +------------------------COMP:V-N(with)------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
                                                         |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 332

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
                                                         +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
                                                         |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 333

                                                         +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
                                                         |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
                                                         |                       |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
                                                         |                       |                         |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 334

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 335

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 336

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 337

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 338

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 339

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 340

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 341

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 342

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           |                                             +------------------------COMP:V-N(with)------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 343

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 344

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |             |        |                      +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |             |        |                      |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 345

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                                             |                               |                 +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                               |                 |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                               |                 |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                               |                 |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                               |                 |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +----MOD_ATT:N-N---+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 346

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 347

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 348

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 349

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+               |                      |                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 350

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 351

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 352

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |                      +---------------------OBJ:V-N--------------------+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 353

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |                      |                                +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |                       |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 354

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 355

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                                              +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |             +--------------------------------OBJ:V-N--------------------------------+         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    |   +------MOD_ATT:N-N------+               |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 356

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |                       +------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 357

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 358

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |                      |    +-------MOD_ATT:N-ADJ-------+               |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 359

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                      |                      |                       |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |                       |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |                       |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |                       |                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 360

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                         +--------------------------------OBJ:V-N--------------------------------+         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
                  +----------------------------COMP:V-N(with)----------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
                  |      |                      +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+------------COMP:V-N(with)------------+            +---MOD_ATT:N-ADJ--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__NODE__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 361

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 362

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      |                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 363

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 364

                                                                                                                                                +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 365

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |                      |                     +----MOD_ATT:N-N---+       |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 366

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                      |                      |                       |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |                       |                         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |                       |                         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 367

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                     +----------------------------------COMP:V-N(In)----------------------------------+                                                                                                                          
           |                                                                                     |         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                     |         |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +--------MOD_ATT:N-N-------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(In) (increase,protein)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 368

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 369

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 370

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 371

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 |                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 372

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 373

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 374

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 375

                                                                                                                                                +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 376

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 377

                                                                                                                                                +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 378

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |                     +----MOD_ATT:N-N---+       |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 379

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 380

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           +------------------------------------COMP:N-N(with)-----------------------------------+                      |                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,protein)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 381

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 382

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 383

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 384

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 385

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                      |                      |                                       |         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |                                       |         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +--------MOD_ATT:N-N-------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 386

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-------------------------------COMP:V-N(In)-------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 387

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      +-------------------------------COMP:V-N(In)-------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 388

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      +-------------------------------COMP:V-N(In)-------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 389

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      +-------------------------------COMP:V-N(In)-------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 390

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
                  +--------------------------------COMP:V-N(with)--------------------------------+         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
                  |                                                   +--------MOD_ATT:N-N-------+         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+------------COMP:V-N(with)------------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 391

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                             +---------COMP:V-N(with)--------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |                                         +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          +SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 392

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                             +---------COMP:V-N(with)--------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |                                         +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          +SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 393

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                             +---------COMP:V-N(with)--------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |                                         +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          +SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 394

                                                         +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
                                                         |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
                                                         |            |                                    +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
                                                         |            |                                    |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 395

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                             +---------COMP:V-N(with)--------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |                                             |            +--COMP:V-N(with)--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          +SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 396

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                         +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
                                                         |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |        |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 397

                                                         +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
                                                         |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
                                                         |                               |                 +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
                                                         |                               |                 |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
                                                         |                               |                 |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
                                                         |                               |                 |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
                                                         |                               |                 |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |        |            +----MOD_ATT:N-N---+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 398

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 399

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 400

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 401

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                                             |            |                                    +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |            |                                    |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 402

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                                             |                               |                 +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                               |                 |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +----MOD_ATT:N-N---+       |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 403

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |             |        |                      +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |             |        |                      |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 404

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |      +----------------COMP:V_PASS-N(with)----------------+                          |                      |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      |      |                      |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 405

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |                      |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 406

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |      +----------------COMP:V_PASS-N(with)----------------+                          |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      |      |                      |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 407

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |                      |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 408

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 409

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 410

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 411

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |      +----------------COMP:V_PASS-N(with)----------------+                          |                      |                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 412

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 413

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |                       +------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 414

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |                      |                                +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+                       |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |                       |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 415

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    |      +----------------COMP:V_PASS-N(with)----------------+                  |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |                  |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |                  +OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |                  |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 416

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    |      +----------------COMP:V_PASS-N(with)----------------+                  |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |                  |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |                  +OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |                  |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 417

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    |      +----------------COMP:V_PASS-N(with)----------------+                  |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |                  |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |                  +OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |                  |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 418

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 419

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |             +--------------------------------OBJ:V-N--------------------------------+         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |      +--------------------------COMP:V_PASS-N(with)-------------------------+       |         |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            +----MOD_ATT:N-N---+       |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__NODE__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 420

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |            |                                    |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 421

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |            |                                    |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 422

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 423

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 424

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 425

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 426

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |            |                                    |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 427

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                      |                      |                               |                 +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |                               |                 |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |                               |                 |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |                               |                 |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |                               |                 |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +----MOD_ATT:N-N---+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 428

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                      |                      |                               |                 +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |                               |                 |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |                               |                 |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |                               |                 |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |                               |                 |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +----MOD_ATT:N-N---+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 429

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |            |                                    |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 430

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                             +---------COMP:V-N(with)--------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 431

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                             +---------COMP:V-N(with)--------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            +--COMP:V-N(with)--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 432

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                             +---------COMP:V-N(with)--------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            +--COMP:V-N(with)--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 433

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                             +---------COMP:V-N(with)--------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            +--COMP:V-N(with)--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 434

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 435

      +-------------------------------COMP:V-N(In)-------------------------------+               +---------------------APPOS--------------------+                                                                                                                                                            
      |    +-------------------------------SUBJ:V-N------------------------------+               |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +----------------------COMP:N-N(with)----------------------+          |               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            |          |               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                  +--MOD_ATT:N-ADJ-+          +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,overproduce)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 436

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 437

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 438

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 439

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |             |        |                      |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 440

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |      +----------------COMP:V_PASS-N(with)----------------+                          |                      |                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      |      |                      |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 441

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                                             |            |                                    +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |            |                                    |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 442

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |                      |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 443

      +-------------------------------COMP:V-N(In)-------------------------------+               +---------------------APPOS--------------------+                                                                                                                                                            
      |    +-------------------------------SUBJ:V-N------------------------------+               |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +----------------------COMP:N-N(with)----------------------+          |               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            |          |               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,overproduce)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 444

      +-------------------------------COMP:V-N(In)-------------------------------+               +---------------------APPOS--------------------+                                                                                                                                                            
      |    +-------------------------------SUBJ:V-N------------------------------+               |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +----------------------COMP:N-N(with)----------------------+          |               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            |          |               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,overproduce)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 445

      +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                                                                                                                                   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       +---------------------APPOS--------------------+                                                                                                                                                            
      |    |      +----------------COMP:V_PASS-N(with)----------------+                  |       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |                  |       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    |      |                             +-------------OBJ:V-N------------+       |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      |                             |    +--MOD_ATT:N-ADJ-+          |       |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,__SP__)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 446

      +-------------------------------COMP:V-N(In)-------------------------------+               +---------------------APPOS--------------------+                                                                                                                                                            
      |    +-------------------------------SUBJ:V-N------------------------------+               |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +----------------------COMP:N-N(with)----------------------+          |               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            |          |               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,overproduce)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 447

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 448

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                                             |            |                                    +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |            |                                    |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 449

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                                             |                               |                 +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                               |                 |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +----MOD_ATT:N-N---+       |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 450

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |                      |                                +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |                       |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 451

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 452

      +-----------------------------------COMP:V-N(In)-----------------------------------+       +---------------------APPOS--------------------+                                                                                                                                                            
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    |      +----------------COMP:V_PASS-N(with)----------------+                  |       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |                  |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      |                             +-------------OBJ:V-N------------+       |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,__SP__)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 453

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +--------------------------COMP:V_PASS-N(with)-------------------------+       |                      |                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            +----MOD_ATT:N-N---+       |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__NODE__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 454

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 455

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |      +--------------------------COMP:V_PASS-N(with)-------------------------+       |                      |                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            +----MOD_ATT:N-N---+       |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__NODE__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 456

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 457

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-------------------------------COMP:V-N(In)-------------------------------+               |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                       |               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 458

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-------------------------------COMP:V-N(In)-------------------------------+               |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                       |               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 459

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 460

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 461

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-------------------------------COMP:V-N(In)-------------------------------+               |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                       |               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 462

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                  +-------------------COMP:V-N(with)------------------+                          |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
                  |                             +---------------------OBJ:V-N--------------------+         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
                  +------------COMP:V-N(with)------------+            |                          |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 463

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                  +-------------------COMP:V-N(with)------------------+                          |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
                  |                             +---------------------OBJ:V-N--------------------+         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
                  +------------COMP:V-N(with)------------+            |                          |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 464

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
                  +-------------------COMP:V-N(with)------------------+                          |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
                  |                             +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+------------COMP:V-N(with)------------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 465

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 466

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 467

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 468

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |             |        |                      +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |             |        |                      |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 469

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 470

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 471

                         +--------------------------------OBJ:V-N--------------------------------+---------------------APPOS--------------------+                                                                                                                                                            
                  +-------------------COMP:V-N(with)------------------+                          |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
                  |      |                      +---------------------OBJ:V-N--------------------+         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
                  +------------COMP:V-N(with)------------+            |                          |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+      |                      |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 472

      +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                                                                                                                                   
      |    +-----------------------------------SUBJ:V-N----------------------------------+                                                                                                                                                                                                                   
      |    |             +------------------------OBJ:V-N------------------------+       |       +---------------------APPOS--------------------+                                                                                                                                                            
      |    |      +----------------COMP:V_PASS-N(with)----------------+          |       |       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |          |       |       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    |      |      |                      +-------------OBJ:V-N------------+       |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      |      |                      |    +--MOD_ATT:N-ADJ-+          |       |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,__SP__)
OBJ:V-N (with,__SP__)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 473

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 474

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

Analyse 475

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)